10 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... suspension 400 mg PO BID ... opportunistic #infections #HIVAIDS ... #pharmacology
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline

First Line Treatment for HCC with Preserved
First Line Treatment ... for Disease Progression ... #Management #Hepatology ... #Gastroenterology ... #oncology #Pharmacology
Complications after Bariatric Surgery
Post Bariatric Intestinal Failure:
 • Severe protein malnutrition after bariatric surgery
 • More
nutrients • TPN for treatment ... (N/V bloating, abd ... Liver Disease in ... excluded limb • Treatment ... and Hepatology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Severe Disseminated Disease ... with ARV (see Table ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
should prevent the disease ... and symptomatic treatment ... 500–1000 mg PO BID ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Preventing CMV Disease ... CMV end-organ disease ... Valganciclovir 900 mg PO BID ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
Doxycycline 100 mg PO BID ... Doxycycline 100 mg PO BID ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Clarithromycin 500 mg PO BID ... please refer to Table ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
Alcohol Use Disorder - Maintenance Treatment
Naltrexone (first line) - First line for most people without contraindications
Dosing: Goal 150 mg BID ... chronic pain, liver disease ... safe in liver disease ... #management #pharmacology ... #table #addiction
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Infection and Disease ... (to prevent TB disease ... Please refer to the table ... opportunistic #infections #HIVAIDS ... #pharmacology